Clinical Trials Logo

Advanced GI Cancer clinical trials

View clinical trials related to Advanced GI Cancer.

Filter by:
  • None
  • Page 1

NCT ID: NCT02268825 Terminated - Advanced GI Cancer Clinical Trials

Phase I Study MK-3475 With Chemotherapy in Patients With Advanced GI Cancers

MK-3475 GI
Start date: January 23, 2015
Phase: Phase 1
Study type: Interventional

This is a Phase I dose escalation trial to assess MTD of MK-3475 in combination with mFOLFOX6 followed by a safety expansion open label, nonrandomized trial with MK-3475 at MTD in combination with mFOLFOX6 and supplemental celecoxib in 4 cohorts of advanced/metastatic GI malignancies (pancreatic, gastro esophageal, colorectal/appendiceal adenocarcinoma and biliary carcinoma) to assess response rate, clinical benefit rate, progression free survival and overall survival. The safety expansion cohort will assess the effect of the addition of celecoxib to patients that do not respond to combination MK-3475/mFOLFOX treatment.